{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:13Z","timestamp":1794330313305,"version":"4.9.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["European J Hybrid Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Muscle enzymes are the major noninvasive diagnostic parameters useful in polymyositis\/dermatomyositis (PM\/DM). Few studies have yet correlated findings on <jats:sup>18<\/jats:sup>F-FDG PET with disease activity in patients with PM\/DM.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Purpose<\/jats:title>\n<jats:p>We evaluated <jats:sup>18<\/jats:sup>F-FDG muscle uptake in patients with PM\/DM compared with non-muscular diseases and correlated the results with serum muscle enzymes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A total of 28 patients with untreated PM\/DM and 28 control patients with non-muscular diseases were examined with <jats:sup>18<\/jats:sup>F-FDG PET\/CT. <jats:sup>18<\/jats:sup>F-FDG uptake was evaluated in 9 proximal skeletal muscle regions bilaterally. The uptake was scored as follows: 0 = less than that of the mediastinal blood vessels, 1 = greater than or equal to that of the mediastinal blood vessels, and 2 = greater than or equal to that of the liver. A score 1 or 2 was considered positive. The mean and maximum standardized uptake values (SUV) were calculated in each muscle and were averaged for all muscle regions. PET findings were correlated with serum muscle enzymes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p><jats:sup>18<\/jats:sup>F-FDG uptake was observed in 82% of patients with PM\/DM and 7% of control patients. The number of positive regions, total score, mean SUVmean, and mean SUVmax in patients with PM\/DM were significantly higher than those in the control patients (all <jats:italic>P<\/jats:italic> &lt; 0.001). The total score of 2 was the best cut-off value that could discriminate patients with PM\/DM from control patients. The total score, mean SUVmean, and mean SUVmax showed significant correlations with creatine kinase (<jats:italic>P<\/jats:italic> = 0.047, 0.002, 0.010, respectively) and aldolase (<jats:italic>P<\/jats:italic> = 0.036, 0.005, 0.038, respectively).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p><jats:sup>18<\/jats:sup>F-FDG PET\/CT using visual and SUV methods demonstrated its usefulness by discriminating PM\/DM from non-muscular diseases and correlating with serum muscle enzymes in patients with PM\/DM.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s41824-020-00084-w","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T23:06:16Z","timestamp":1597187176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["18F-FDG PET\/CT in patients with polymyositis\/dermatomyositis: correlation with serum muscle enzymes"],"prefix":"10.1186","volume":"4","author":[{"given":"Hanae","family":"Arai-Okuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Norikane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3912-4217","authenticated-orcid":false,"given":"Yuka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Mitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasukage","family":"Takami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Wakiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusaku","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"84_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"84_CR2","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487\u20131498","journal-title":"N Engl J Med"},{"key":"84_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet. 362:971\u2013982","journal-title":"Lancet."},{"key":"84_CR4","unstructured":"Engel AG, Hohlfeld R. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology. 3rd edn. McGraw-Hill, 2004:1321\u201366."},{"key":"84_CR5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2967\/jnumed.110.076232","volume":"51","author":"M Gotthardt","year":"2010","unstructured":"Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ (2010) Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med 51:1937\u20131949","journal-title":"J Nucl Med"},{"key":"84_CR6","first-page":"29","volume":"34","author":"RS Jackson","year":"2006","unstructured":"Jackson RS, Schlarman TC, Hubble WL, Osman MM (2006) Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J Nucl Med Technol 34:29\u201333","journal-title":"J Nucl Med Technol"},{"key":"84_CR7","first-page":"1972","volume":"33","author":"R Kubota","year":"1992","unstructured":"Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972\u20131980","journal-title":"J Nucl Med"},{"key":"84_CR8","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3899\/jrheum.111597","volume":"39","author":"T Owada","year":"2012","unstructured":"Owada T, Maezawa R, Kurasawa K, Okada H, Arai S, Fukuda T (2012) Detection of inflammatory lesions by F-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol 39:1659\u20131665","journal-title":"J Rheumatol"},{"key":"84_CR9","first-page":"570","volume":"30","author":"N Pipitone","year":"2012","unstructured":"Pipitone N, Versari A, Zuccoli G, Levrini G, Macchioni P, Bajocchi G et al (2012) 18F-fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series. Clin Exp Rheumatol 30:570\u2013573","journal-title":"Clin Exp Rheumatol"},{"key":"84_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/jnnp-2011-301712","volume":"83","author":"D Renard","year":"2012","unstructured":"Renard D, Chiper L, Collombier L, Labauge P (2012) Increased muscle FDG-PET uptake in dermatomyositis. J Neurosurg Psychiatry 83:487","journal-title":"J Neurosurg Psychiatry"},{"key":"84_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CDLI.2.1.1-9.1995","volume":"2","author":"LG Rider","year":"1995","unstructured":"Rider LG, Miller FW (1995) Laboratory evaluation of the inflammatory myopathies. Clin Diagn Lab Immunol 2:1\u20139","journal-title":"Clin Diagn Lab Immunol"},{"key":"84_CR12","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","volume":"52","author":"S Tanaka","year":"2013","unstructured":"Tanaka S, Ikeda K, Uchiyama K, Iwamoto T, Sanayama Y, Okubo A et al (2013) [18F]FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis. Rheumatology 52:1271\u20131278","journal-title":"Rheumatology"},{"key":"84_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006763","volume":"5","author":"M Tateyama","year":"2015","unstructured":"Tateyama M, Fujihara K, Misu T, Arai A, Kaneta T, Aoki M (2015) Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation. BMJ Open 5:e006763","journal-title":"BMJ Open"},{"key":"84_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.crad.2015.03.010","volume":"70","author":"S Vaidyanathan","year":"2015","unstructured":"Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU (2015) FDG PET\/CT in infection and inflammation--current and emerging clinical applications. Clin Radiol 70:787\u2013800","journal-title":"Clin Radiol"}],"container-title":["European Journal of Hybrid Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-020-00084-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-020-00084-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-020-00084-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T23:06:14Z","timestamp":1628723174000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhi.springeropen.com\/articles\/10.1186\/s41824-020-00084-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1186\/s41824-020-00084-w","relation":{},"ISSN":["2510-3636"],"issn-type":[{"value":"2510-3636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional ethical review committee (approval number 2020044). Written informed consent was obtained from PM\/DM patients. The requirement for informed consent for control was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All images and data were anonymous.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}